肝源性糖尿病的治疗现状

于明霞; 尹威民; 李迎今; 吴扬

肝源性糖尿病的治疗现状

吉林大学第一医院急诊科

详细信息

中图分类号: R587.1
计量
- 文章访问数: 4343
- HTML全文浏览量: 20
- PDF下载量: 1500
- 被引次数: 0
出版历程
- 出版日期: 2011-07-20

The treatment status of hepatogenous diabetes

摘要

摘要: 肝源性糖尿病是指继发于肝病并发症的糖尿病,被认为是肝功能恶化的标志。在我国各型肝炎、肝硬化发病率较高,因此肝源性糖尿病很常见。临床治疗以治疗原发病(肝病)为主,降糖治疗为辅。
- 糖尿病 /
- 2型 /
- 肝疾病
Abstract: Diabetes developed as a complication of liver diseases is known as hepatogenous diabetes (HD) , and it may be considered as a marker for liver function deterioration.Because of high incidence of hepatitis and cirrhosis, there are many patients with HD.In clinical work, we should treat the original disease (liver disease) following up with the treatment for control blood sugar.
- diabetes mellitus /
- type 2 /
- liver diseases

HTML全文

参考文献(34)

[1]戴青, 贾文梅, 王力.肝硬化并发糖尿病胰腺超声改变的探讨[J].中国超声诊断杂志, 2006, 7 (6) :464.

[2]姜丽萍, 赵金满.肝源性糖尿病的诊断与治疗[J].世界华人消化杂志, 2007, 15 (6) :617-621.

[3]Holstein A, Hinze S, Thiessen E, et al.Clinical in plications of hepalogenous diabetes in liver cirrhosis[J].Gastroenterol Hepato, 2002, 17 (6) :677-681.

[4]Zhang L.Diagnostic value of serum islet autoantibody in hepatogenic diabetes mellitus[J].Nan Fang Yi Ke Da Xue Xue Bao, 2006, 26 (7) :1034-1036.

[5]Edvardsson U, von Lowenhielm HB, Panfilov O, et al.Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators[J].Proteomics, 2003, 3 (4) :468-478.

[6]王建华.肝源性糖尿病的诊治[J].家庭医学, 2008, (11) :49.

[7]Link JT.Pharmacological regulation of hepatic glucose production[J].Curr Opin Invesfig Drugs, 2003, 4 (4) :421-429.

[8]Petrides AS, Vogt C, Schdze-Berge D, et al.Pathogsnesis ofglucose intolerance and diabetes meHitm in cirrhoeis[J].Hepatology, 1994, 19 (3) :616-627.

[9]Leme JA, Silveira RF, Comes RI, et al.Long-term physical training increases liver IGF-I in diabetic rats[J].Growth Horm IGF Res, 2009, 19 (3) :262-266.

[10]McGuinness OP, Cherrington AD.Effects of fructose on hepatic glucose metabolism[J].Curr Opin Clin Nutr Metab Care, 2003, 6 (4) :441-448.

[11]李学庆, 索丽霞, 邵亚军.瑞格列奈致肝损害3例[J].药物不良反应杂志, 2009, 11 (3) :206-207.

[12]Du K, Herzig S, Kulkami RN, et al.TRB3:a tribbles homolog that Inhibits Akt/PKB activation by insulin in liver[J].Science, 2003, 300 (5625) :1574-1577.

[13]Puigserver P, Rhee J, Donovlul J, et al.lnsulin-regulated hepatic gluconeogenesis through FOXO1-PGC-lalpha interaction[J].Nature, 2003, 423 (6939) :550-555.

[14]王鹏.二甲双胍联合天晴甘平治疗非酒精性脂肪性肝病51例疗效观察[J].山东医药, 2010, 50 (23) :83.

[15]张智峰, 赵钢, 朱英, 等.二甲双胍治疗成年人非酒精性脂肪性肝病的荟萃分析[J].世界华人消化杂志, 2010, 18 (16) :1717-1723.

[16]Yoneda M, Endo H, Nozaki Y, et al.Life style-related diseases of the digestive system:gene expression in nonalcoholic steatohepatitis patients and treatment strategies[J].J Pharmacol Sci, 2007, 105 (2) :151-156.

[17]Gentile S, Turco S, Guarino G, et al.Norr-insulin-dependent diabetes mellitus associated with nonalcoholic liver cirrhosis:an evaluation of treatment with the intestinal alpha-glucosidase inhibitor acarbose[J].Ann Ital Med Int, 1999, 14 (1) :7-14.J Clini Hepatol, July 2011, Vol.27, No.7

[18]孙贺营.肝源性糖尿病中医病机论治探源[J].中国医药指南, 2008, 6 (23) :295-297.

[19]孙贺营.从肝论治肝源性糖尿病体会[J].中医杂志, 2009, 50 (6) :501-502.

[20]徐春军.保肝愈消方治疗116例肝性糖尿病临床研究[J].中国医药学报, 1997, 12 (5) :25-26.

[21]黄笑夏, 欧阳钦.黄连免煎颗粒治疗肝源性糖尿病临床观察[J].天津药学, 2008, 20 (3) :41-42.

[22]Alvarsson M, Sundkvist G, Lager I, et al.Effect of insulin vs glibenclamidein recently diagnosed patient with type 2 diabetes:a 4-year follow-up[J].Diabetes Obes, 2008, 10 (5) :421-429.

[23]Holman RR, Paul SK, Bethel MA, et al.10-year follow-up of in-tensive glucose control in type 2 diabetes[J].N Engl J Med, 2008, 59 (15) :1577-1589.

[24]Gentile S, Turco S, Guarino G, et al.Effect of treatment with acarbose and insulin in patients with non-insulin dependent diabetes mellitus associated with non-alcoholic liver cirrhosis[[J].Diabetes Obes Metab, 2001, 3 (1) :33-34.

[25]Bode BW, Strange P.Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes[J].Diabetes Care, 2001, 24 (1) :69-72.

[26]许雯, 李延兵, 翁建平.速效胰岛素类似物临床应用进展[J].中国实用内科杂志, 2008, 28 (4) :304-306.

[27]Light JA, Barhyte DY, Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease:similar 10-year outcomes[J].Transplant Proc, 2005, 37 (2) :1283-1284.

[28]Nath DS, Gruessner AC, Kandaswamy P, et al.Outcomes of pancreas transplants for paticnts with type 2 diabetes mellitus[J].Clin Transplant, 2005, 19 (6) :792-797.

[29] 齐海智, 贺志军, 司中州, 等.肝、胰I期联合移植治疗合并糖尿病的良性终末期肝病一例[J].中华器官移植杂志, 2008, 29 (7) :408-410.

[30]李晓东.2型糖尿病的外科治疗进展[J].中外医疗, 2011, 3:179-180.

[31]Chang C, Wang X, Niu D.Mesenchymalstem cells adopt beta-cell fate upon diabetic pancreatic microenvironment[J].Pancreas, 2009, 38 (3) :275-281.

[32]HoriY.Insulin-producing cells derived from stem/progenitor cells therapeutic implications for diabetes mellitus[J].Med Mol Morpho, 2009, 42 (4) :195-200.

[33]沈山梅, 李莉蓉, 周世海, 等.自体造血干细胞移植治疗1型糖尿病-附一例报告[J].中国糖尿病杂志, 2008, 16 (9) :554-556.

[34]游说, 张清, 周智广.糖尿病基因治疗的研究新进展[J].国际病理科学与临床杂志.2011, 31 (1) :69-72.

施引文献

资源附件(0)

访问统计